BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Galena Biopharma  

310 N. State Street, Suite 208

Lake Oswego   Oregon  97034  U.S.A.
Phone: 1-503-400-7636 Fax: 1-503-400-6611


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Galena Biopharma  (GALE) To Report Fourth Quarter And Year End 2014 Financial Results On Thursday, March 5, 2015 2/19/2015 8:32:14 AM
Galena Biopharma  (GALE) Enrolls 700th Patient In Neuvax (Nelipepimut-S) Phase 3 PRESENT Clinical Trial 2/9/2015 7:24:41 AM
Galena Biopharma  (GALE) Announces Orexo AB (ORXOF)'s Filing Of A Patent Infringement Lawsuit Against Actavis (ACT) Concerning Abstral (Fentanyl) Sublingual Tablets In The U.S. 2/5/2015 7:52:43 AM
Galena Biopharma  (GALE) To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 1/28/2015 8:00:17 AM
Galena Biopharma  (GALE) Hires Joseph Lasaga As Vice President, Business Development And Alliance Management 1/20/2015 7:36:45 AM
Galena Biopharma  (GALE) To Present At The Noble Financial Capital Markets 11th Annual Investor Conference 1/15/2015 7:21:50 AM
Galena Biopharma  (GALE) Provides 2015 Outlook 1/8/2015 1:18:06 PM
Galena Biopharma  (GALE) Presents HER2 Screening Data Including Preliminary Leica Bond Oracle™ Results From the Phase 3 NeuVax™ (nelipepimut-S) Clinical Trial at the 2014 San Antonio Breast Cancer Symposium (SABCS) 12/11/2014 7:45:28 AM
Galena Biopharma  (GALE) Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data At The 56th American Society of Hematology Annual Meeting & Exposition 12/8/2014 8:27:46 AM
Galena Biopharma  (GALE) To Present HER2 Screening Data From The Phase 3 Neuvax™ (Nelipepimut-S) Clinical Trial At The 2014 San Antonio Breast Cancer Symposium (SABCS) 12/8/2014 7:26:26 AM
12345678910...